Nomura Holdings’s 89bio ETNB Stock Holding History

Nomura Holdings’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-99,997	Closed	-$740K	–	2240
2024 Q3	$740K	Buy	99,997 +4,988	+5%	+$41.9K	﹤0.01%	1185
2024 Q2	$761K	Buy	95,009 +36,046	+61%	+$322K	﹤0.01%	1215
2024 Q1	$686K	Sell	58,963 -23,037	-28%	-$255K	﹤0.01%	1200
2023 Q4	$916K	Buy	+82,000	New	+$754K	﹤0.01%	1204

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Nomura Holdings's ETNB Position: Q4 2024 in Review

Nomura Holdings sold out of 89bio (ETNB) in Q4 2024, closing a stake of 99,997 shares — an estimated $740K sold.

Nomura Holdings first reported a position in ETNB in Q4 2023 and held it in 4 quarters. The position peaked at $916K in Q4 2023. 155 funds tracked by Wall St. Rank hold ETNB as of Q4 2024.

Nomura Holdings reported no remaining 89bio position as of Q4 2024 after selling out during the quarter.
Nomura Holdings sold 99,997 89bio shares in Q4 2024, an estimated $740K.
Nomura Holdings first reported a position in 89bio in Q4 2023 and held it in 4 quarters.
Nomura Holdings's 89bio position peaked at $916K in Q4 2023.
155 funds tracked by Wall St. Rank held 89bio as of Q4 2024.

Based on Nomura Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.